As a result, oncolytic virus can be a more effective tool to eliminate a CD133+ cells than an anti-CD133 antibody because progeny of oncolytic virus is continuously produced in the tumor and keep attacking CD133+ cancer cells. Here, PROM1 is linked to neoplasm.